Sign in

Jeffrey V Lazarus

@jvlazarus.bsky.social
422 followers 185 following 35 posts

Professor of Global Health #LiverSky

PostsRepliesMedia
Reposted by Jeffrey V Lazarus
Health Policy Watch - Global health news reporting @healthpolicywatch.bsky.social · 26/05/2026
A new #WHA79 resolution on steatotic #liver disease could shift liver health from the margins of #hepatology to the centre of the global NCD response. ⚠️The message: the liver is already warning us about the metabolic crisis. INSIDE VIEW: @jvlazarus.bsky.social @isglobal.org 📖⬇️ & 🔁🙏
healthpolicy-watch.news
From Margin To Mainstream: Why Liver Health Should Sit At The Centre Of The Global NCD Response - Health Policy Watch
The 79th World Health Assembly adopted the first-ever resolution on steatotic liver disease (SLD) last week. For those people working outside hepatology, the
085
Reposted by Jeffrey V Lazarus
ISGlobal @isglobal.org · 19/12/2025
#MASLD affects more than one third of adults worldwide, yet #LiverHealth remains under-prioritised in #NCD agendas. New global consensus highlights evidence-based, affordable interventions that can be implemented now. 🟠 ja.cat/vbaMk cc @lancetgastrohep.bsky.social @jvlazarus.bsky.social
021
Reposted by Jeffrey V Lazarus
CUNY Graduate School of Public Health & Health Policy @sph.cuny.edu · 03/12/2025
Five #CUNYSPH scholars have been named to Clarivate's 2025 Highly Cited Researchers list, the top 1% of researchers globally. Congratulations to Dean Ayman El-Mohandes, Prof. Levi Waldron , Prof. Jeffrey V Lazarus, Dist. Lecturer Ratzan, and Senior Scholar Kenneth Rabin. cunysph.me/4obbhMa
cunysph.me
Clarivate’s 2025 Highly Cited Researchers include five from CUNY SPH - CUNY Graduate School of Public Health & Health Policy
Five CUNY SPH faculty and senior scholars are featured among Clarivate’s Highly Cited Researchers for 2025. Dean Ayman El-Mohandes, Professor Jeffrey Lazarus, Senior Scholar Kenneth Rabin, Distinguished Lecturer Scott Ratzan, and Professor Levi Waldron made...
031
Reposted by Jeffrey V Lazarus
CUNY Graduate School of Public Health & Health Policy @sph.cuny.edu · 07/10/2025
🏈🩺 #CUNYSPH Prof. Bruce Y Lee explores NFL legend Dan Marino’s MASH (metabolic dysfunction–associated steatohepatitis) diagnosis in Forbes featuring insights from Prof. Jeffrey V Lazarus on the prevalence and public health risks of liver disease. cunysph.me/48CD1Vx
cunysph.me
NFL Legend Dan Marino Talks About His MASH, Liver Disease Diagnosis
NFL Hall of Fame quarterback Dan Marino has revealed his metabolic dysfunction-associated steatohepatitis or MASH diagnosis. Here's what this liver disease is.
022
Reposted by Jeffrey V Lazarus
CUNY Graduate School of Public Health & Health Policy @sph.cuny.edu · 03/10/2025
A new Politico piece on chronic diseases quotes #CUNYSPH Prof. Jeffrey V Lazarus on how food environments shape health more than “individual choice”. 💬 “What are the options, what’s available, do you even have the ability to purchase healthy foods?” Read more: cunysph.me/4gPQMT7
cunysph.me
Chronic diseases are squeezing economies. Leaders don’t have much of a plan.
The United Nations General Assembly is expected to sign off on a watered-down commitment to tackle noncommunicable diseases.
021
Jeffrey V Lazarus @jvlazarus.bsky.social · 03/10/2025
Tx for sharing. My question for Spain's secretary of health comes at 1 hour 9 min. It's about the commercial determinants of health and how Spain can reconcile its work to reduce NCDs while fomenting the sale of alcohol. youtu.be/p3wYHX8I5eg?... Our call to action: www.thelancet.com/journals/lan...
youtu.be
Shaping the Spanish National Health System with a Global Health Perspective, Sept 18, 2025
YouTube video by CUNY SPH
000
Reposted by Jeffrey V Lazarus
Wilton Park @wiltonpark.bsky.social · 17/09/2025
💬 'Wilton Park has shown to be a powerful outlet to reach world leaders and shape strategic health discussions.' In our latest blog, @jvlazarus.bsky.social explains how his partnership with Wilton Park has delivered policy impact. #WiltonPark80 🔗 wiltonpark.org.uk/idea/80-year...
A view of Wiston House. Text reads: New blog - 80 years of Wilton Park: Professor Jeffrey V Lazarus
022
Reposted by Jeffrey V Lazarus
LIVERAIM @liveraim.bsky.social · 28/07/2025
🚨 Don't miss the third webinar of the #LIVERAIM series! 📹 youtube.com/watch?v=qdM_... #SLDthinktank @jvlazarus.bsky.social @ihieurope.bsky.social @easlnews.bsky.social @majathiele.bsky.social @salvatore-piano.bsky.social @aleksanderkrag.bsky.social
youtube.com
LIVERAIM webinar #3: A Deep Dive into Steatotic Liver Disease Policy and Regulatory Processes
YouTube video by LIVERAIM
022
Reposted by Jeffrey V Lazarus
LIVERAIM @liveraim.bsky.social · 29/06/2025
😶Liver disease is often suffered in silence. Stigma and shame block care. 💡It’s a chronic illness, not consequence of bad choices. 🩺Everyone deserves support. At #LIVERAIM, we’re breaking the silence. #EndTheStigma #LiverHealthMatters #HealthEquity @ihieurope.bsky.social @easlnews.bsky.social
244
Jeffrey V Lazarus @jvlazarus.bsky.social · 29/06/2025
Read about stigma in the EASL-Lancet liver health commission: www.thelancet.com/journals/lan... #LiverSky
thelancet.com
The EASL–Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality
Liver diseases have become a major health threat across Europe, and the face of European hepatology is changing due to the cure of viral hepatitis C and the control of chronic viral hepatitis B, the i...
010
Reposted by Jeffrey V Lazarus
Nature Reviews Gastroenterology & Hepatology @natrevgastrohep.nature.com · 09/06/2025
Happy to support and endorse the People First Liver Charter in ‪‪@natmed.nature.com‬‬ www.nature.com/articles/s41... We've always taken a sensitive approach to the language used in our journal, and will continue to do so. See this Editorial www.nature.com/articles/s41...
nature.com
The People-First Liver Charter - Nature Medicine
Reducing the stigma and discrimination that people living with liver conditions experience requires rethinking how diagnoses, diseases, etiologies and circumstances are perceived — a shift that begins...
022
Reposted by Jeffrey V Lazarus
Philippa Matthews @pippa-matt.bsky.social · 09/06/2025
The People-First Liver Charter - opportunities for improving awareness, tackling stigma, building accessible care pathways, maintaining linkage to treatment/monitoring, & reducing health inequities. 🧪 Led by @jvlazarus.bsky.social #NoHep #MedSky #HepSky #LiverSky www.nature.com/articles/s41...
nature.com
The People-First Liver Charter - Nature Medicine
Reducing the stigma and discrimination that people living with liver conditions experience requires rethinking how diagnoses, diseases, etiologies and circumstances are perceived — a shift that begins...
022
Jeffrey V Lazarus @jvlazarus.bsky.social · 08/06/2025
At the Global Think-tank on Steatotic Liver Disease, we launched the People-First Liver Charter www.nature.com/articles/s41... + A call for doubling the diagnostic rate of at-risk MASH www.thelancet.com/journals/lan... #SLDthinktank #InMotionTogether #LiverSky
nature.com
The People-First Liver Charter - Nature Medicine
Reducing the stigma and discrimination that people living with liver conditions experience requires rethinking how diagnoses, diseases, etiologies and circumstances are perceived — a shift that begins...
061
Reposted by Jeffrey V Lazarus
ISGlobal @isglobal.org · 29/05/2025
Congratulations to @jvlazarus.bsky.social on receiving the Eugene T. Davidson Public Service Award from the American Association of Clinical Endocrinology! This award recognises exceptional contributions to clinical excellence, research, public health, and community engagement in #endocrinology.
052
Jeffrey V Lazarus @jvlazarus.bsky.social · 19/04/2025
Here we are in Spanish talking liver health. #WorldLiverDay
021
Jeffrey V Lazarus @jvlazarus.bsky.social · 19/04/2025
Food inequity and insecurity and MASLD: burden, challenges, and interventions www.nature.com/articles/s41... @natrevgastrohep.nature.com is a major theme of #WorldLiverDay: worldliverday.org/food-is-medi... #LiverSky @easlnews.bsky.social #HealthyLiversHealthyLives
nature.com
Food inequity and insecurity and MASLD: burden, challenges, and interventions - Nature Reviews Gastroenterology & Hepatology
Metabolic dysfunction-associated steatotic liver disease (MASLD) prevalence is increasing worldwide, and a crucial risk factor is food insecurity. This Review provides an extensive overview of food in...
031
Jeffrey V Lazarus @jvlazarus.bsky.social · 19/04/2025
We support the @ncdalliance priorities for the 4th United Nations High-level Meeting on NCDs Political Declaration sldthinktank.com/un-hlm-2025-... and further call on UN Member States to develop #BestBuy interventions to address SLD: www.thelancet.com/journals/lan... #LiverSky #SLDthinktank
sldthinktank.com
041
Jeffrey V Lazarus @jvlazarus.bsky.social · 19/04/2025
Read about Chronic Liver Disease, MASLD/MASH, and the Global NCD Agenda in the context of the United Nations General Assembly High-level Meeting on NCDs this Sept. We need to take action every day and not just on #WorldLiverDay! sldthinktank.com/un-hlm-2025-... #liversky #SLDthinktank
232
Reposted by Jeffrey V Lazarus
LIVERAIM @liveraim.bsky.social · 19/04/2025
🌎Did you know 1 in 3 adults worldwide has #MASLD? It’s tied to obesity, diabetes & high cholesterol, it can lead to fibrosis and cancer. This #WorldLiverDay remember: #FoodIsMedicine! 💪Let's make #liverhealth a priority @easlnews.bsky.social @ihieurope.bsky.social @europeliver.bsky.social
167
Jeffrey V Lazarus @jvlazarus.bsky.social · 05/04/2025
"Food is Medicine" -But for whom? The accessibility problem in nutrition and liver health: worldliverday.org/food-is-medi... #WorldLiverDay #SLDthinktank #LiverSky @easlnews.bsky.social @ebtapper.bsky.social @aleksanderkrag.bsky.social @debbieshawcross.bsky.social @melinamanolas.bsky.social
worldliverday.org
051
Reposted by Jeffrey V Lazarus
Hannes Hagström @liverepi.bsky.social · 24/03/2025
New paper from us in @jhepatology.bsky.social: www.journal-of-hepatology.eu/article/S016... Causes of death in >13,000 persons with #MASLD - check it out #liversky. So proud of co-senior author Axel Wester and first author medical student Gabriel Issa for the work!
journal-of-hepatology.eu
Cause-specific mortality in 13,099 patients with metabolic dysfunction-associated steatotic liver disease in Sweden
Data on cause-specific mortality in metabolic dysfunction-associated steatotic liver disease (MASLD) are limited. We aimed to determine the rate and risk of death from different causes in patients wit...
1176
Jeffrey V Lazarus @jvlazarus.bsky.social · 26/03/2025
It's a must-read #LiverSky
020
Reposted by Jeffrey V Lazarus
LIVERAIM @liveraim.bsky.social · 20/03/2025
❓Did you miss the second #LIVERAIM webinar? Check out our Youtube channel and discover what an #earlydiagnosis of #chronicliverdisease truly means for patients! 🎥 www.youtube.com/watch?v=jmw5... @easlnews.bsky.social @ihieurope.bsky.social @europeliver.bsky.social
youtube.com
Early diagnosis of Chronic Liver Disease - What does it means for patients?
YouTube video by LIVERAIM
145
Reposted by Jeffrey V Lazarus
Nature Reviews Disease Primers @natrevdiseaseprimers.nature.com · 12/03/2025
Metabolic dysfunction-associated steatotic liver disease encompasses a spectrum from metabolic dysfunction-associated steatotic liver or isolated hepatic steatosis through to metabolic dysfunction-associated steatohepatitis (#MASH). #MASLD www.nature.c...
011
Jeffrey V Lazarus @jvlazarus.bsky.social · 16/03/2025
New Nature disease primer on #MASLD out now. MASLD affects 1 in 3 adults, yet it’s still underrecognized beyond #hepatology. That’s why our multidisciplinary team collaborated to cover epidemiology, diagnosis, treatment & prevention 🔗https://www.nature.com/articles/s41572-025-00599-1 #LiverSky
030
Reposted by Jeffrey V Lazarus
Rui Castro @ruicastrohd.bsky.social · 12/03/2025
In a related topic, more about MASLD in an amazing Nature Reviews Disease Primers article just published: 🔗 nature.com/articles/s41... @jvlazarus.bsky.social
011
Jeffrey V Lazarus @jvlazarus.bsky.social · 03/03/2025
The second @liveraim.bsky.social webinar is now underway...! You can view the first webinar on demand here: www.liveraim.eu/webinars/ #LiverSky LIVERAIM is working to improve early detection of chronic liver disease through the development of a new biomarker-based personalized risk calculator.
000
Reposted by Jeffrey V Lazarus
LIVERAIM @liveraim.bsky.social · 02/03/2025
📌Tomorrow is the day: don't miss the 2nd #LIVERAIM webinar! ✒️Register now! tinyurl.com/bdhyjv8e @europeliver.bsky.social @easlnews.bsky.social @jvlazarus.bsky.social @aleksanderkrag.bsky.social @mkdmilan.bsky.social @majathiele.bsky.social @worldhepalliance.bsky.social
tinyurl.com
Early diagnosis of Chronic Liver Disease – What does it mean for patients? – LiverAim
153
Jeffrey V Lazarus @jvlazarus.bsky.social · 01/03/2025
WHO "emphasizes the value of an integrated approach to HIV", drawing on our important evidence: "Integrated management of HIV, diabetes, and hypertension in sub-Saharan Africa (#INTEAFRICA): a pragmatic cluster-randomised, controlled trial" www.thelancet.com/journals/lan... @gavinyamey.bsky.social
thelancet.com
Integrated management of HIV, diabetes, and hypertension in sub-Saharan Africa (INTE-AFRICA): a pragmatic cluster-randomised, controlled trial
In sub-Saharan Africa, integrated chronic care services could achieve a high standard of care for people with diabetes or hypertension without adversely affecting outcomes for people with HIV.
000
Reposted by Jeffrey V Lazarus
LIVERAIM @liveraim.bsky.social · 27/02/2025
⌛️4 day left! Join 2nd #LIVERAIM webinar and learn what patients really think about #earlydiagnosis: the hopes, the fears, and the reality! 🗓️3 March 17:30-18:10 CET 👉Register now tinyurl.com/bdhyjv8e @europeliver.bsky.social @easlnews.bsky.social @jvlazarus.bsky.social @aleksanderkrag.bsky.social
032
Reposted by Jeffrey V Lazarus
LIVERAIM @liveraim.bsky.social · 20/02/2025
📣 The second #LIVERAIM webinar is on the way! Early diagnosis of chronic liver disease - What does it mean for patients? 🗓️ 3 March 17:30-18:10 CET 🔗 Register now! tinyurl.com/4j97xhp9 #earlydiagnosis #changingtheparadigm @easlnews.bsky.social @aleksanderkrag.bsky.social @jvlazarus.bsky.social
055
Reposted by Jeffrey V Lazarus
Eric Topol @erictopol.bsky.social · 24/01/2025
Welcome immigrants from X interested in science to the friendlier skies of @bsky.app, as documented by a new @nature.com survey (but you already knew that 😉) "Bluesky is much better for science. There is much less toxicity, misinformation, and distractions." www.nature.com/articles/d41...
242153762372
Jeffrey V Lazarus @jvlazarus.bsky.social · 23/01/2025
The 🌎 burden of #MASH is staggering: 5.3% of adults face higher risks of cirrhosis, liver cancer & other complications as fibrosis progresses. our latest study on MAESTRO-NASH resmetirom data & its real-world implications post-FDA approval www.nature.com/articles/s44... #SLDsummit
021
Jeffrey V Lazarus @jvlazarus.bsky.social · 23/01/2025
Dr @aleksanderkrag.bsky.social kicks off the #SLDsummit. First session is the SLD patient trajectory, proud to have contributed to it. We're joining after a fabulous visit to the Portuguese diabetes centre in Lisbon yesterday... @easlnews.bsky.social
140
Reposted by Jeffrey V Lazarus
World Hepatitis Alliance @worldhepalliance.bsky.social · 13/01/2025
Hi #BlueSky! We are an international network of organisations working in over 100 countries towards the goal of eliminating hepatitis by 2030. Looking forward to connecting with likeminds! Learn more about us: www.worldhepatitisalliance.org
worldhepatitisalliance.org
World Hepatitis Alliance
Fighting for a world free from viral hepatitis
0106
Jeffrey V Lazarus @jvlazarus.bsky.social · 15/01/2025
Today, I discussed the Lancet obesity commission on @AJEnglish. It's timely w the UN High-level Meeting on NCDs taking place in Sept. Obesity and MASLD go hand in hand and need to be part of the UN declaration, along w diabetes, cancer, CVD www.thelancet.com/commissions/... #LiverSky
030
Reposted by Jeffrey V Lazarus
EASL @easlnews.bsky.social · 15/01/2025
2025 is the perfect year to take your career to the next level🚀 There are also 6 positions to fill in the EASL Scientific Committee, Policy Public Health and Advocacy Committee, Ethics and Compliance Committee and Nurses & AHPs Task Force. Apply by 20 January: easl.eu/leadership25 #LiverSky
0125
Reposted by Jeffrey V Lazarus
WHO @who.int · 12/01/2025
There is no health without #MentalHealth💚 In 2025, let's make sure mental health is given the same priority as physical health by standing up against stigma and ensuring more people can access the support they need.
Reminder. There is no health without mental health.
629376
Reposted by Jeffrey V Lazarus
Gregg Gonsalves @gregggonsalves.bsky.social · 12/01/2025
How much would buying the Sudetenland cost? We asked the experts. www.nytimes.com/2025/01/11/b...
nytimes.com
Trump Wants to Buy Greenland, But How Much Would It Actually Cost?
President-elect Donald Trump wants to buy the territory from Denmark, which says it’s not for sale. DealBook asked experts how they’d approach the deal.
5509
Reposted by Jeffrey V Lazarus
JAMA @jama.com · 11/01/2025
In 1964, the World Medical Association adopted the first version of its Declaration of Helsinki. This Viewpoint discusses key revisions of the Declaration of Helsinki 2024 in the context of internationally accepted ethical guidance for human research. ja.ma/3C4qXyD
Image shows PDF.
093
Reposted by Jeffrey V Lazarus
Philippa Matthews @pippa-matt.bsky.social · 11/01/2025
Recent work showing diverse treatment responses in #HBV infection. Treatment can work well but we need to understand it better, & focus on those in whom viraemia is not suppressed. @oxhealthbrc.bsky.social @nihr.bsky.social @crick.ac.uk #HepSky 🧪 JHEP REP www.jhep-reports.eu/article/S258...
Image shows classification of HBV viral load into groups according to treatment response.
055
Reposted by Jeffrey V Lazarus
Paul Belcher FRCP HonMFPH 🇪🇺🇬🇧 @pauljbelcher.bsky.social · 10/01/2025
📚New study: Increasing value-added taxes rates on meat and dairy and reducing #VAT on fruits and vegetables can improve diets and result in #health, environmental and economic benefits in #Europe @naturefood.bsky.social www.nature.com/articles/s43...
nature.com
A reform of value-added taxes on foods can have health, environmental and economic benefits in Europe - Nature Food
Fiscal incentives on consumption can encourage dietary changes towards healthier and more sustainable foods. Integrated modelling reveals the potential health, environmental and economic impacts of al...
063
Jeffrey V Lazarus @jvlazarus.bsky.social · 09/01/2025
2.5 years later, in Nov 2022, "A multinational Delphi consensus to end the COVID-19 public health threat" was published- A panel of 386 experts from 112 countries recommended specific actions to end this persistent global threat to #publichealth. www.nature.com/articles/s41... @nature.com
nature.com
A multinational Delphi consensus to end the COVID-19 public health threat - Nature
A diverse, multidisciplinary panel of 386 experts in COVID-19 response from 112 countries provides health and social policy actions to address inadequacies in the pandemic response and help to bring t...
000
Jeffrey V Lazarus @jvlazarus.bsky.social · 09/01/2025
I miss getting the hard copies at home. They were my preferred travel reading and when done I'd give the copy to someone. Bygone days...
010
Reposted by Jeffrey V Lazarus
Elliot Tapper @ebtapper.bsky.social · 09/01/2025
The greatest review written on liver biopsy: indications, interpretation, and its future By Dr Purva Gopal and colleagues in HepCommJournal Open access journals.lww.com/hepcomm/full... #liversky #pathsky
23412
Jeffrey V Lazarus @jvlazarus.bsky.social · 08/01/2025
I'm very much looking forward to the EASL #SLDsummit in 2 weeks. We have an oral on MASLD #BestBuys, 2 posters on #MASHcities and one on the cost of Inaction. I'll also chair the #publichealth session - don't miss it. #LiverSky
050
Jeffrey V Lazarus @jvlazarus.bsky.social · 08/01/2025
1000 tak!
010
Reposted by Jeffrey V Lazarus
The New York Times @nytimes.com · 07/01/2025
Peter Yarrow, whose vocals for the trio Peter, Paul and Mary helped establish them as one of the most popular folk acts of the 1960s, died on Tuesday at 86. The folk trio became a pop phenomenon with hits like “If I Had a Hammer” and “Puff the Magic Dragon.” nyti.ms/3PqOFIp
A black-and-white photo of Peter Yarrow with shaggy dark hair on the back of his head, a bushy mustache and glasses smiling and playing an acoustic guitar. The text reads: "1935-2025. Peter Yarrow, Singer of Peter, Paul and Mary Dies at 86." Photo by Sherry Rayn Barnett via Getty Images
56971181
Reposted by Jeffrey V Lazarus
SALVE @salve-liver.bsky.social · 07/01/2025
Alcohol and MASLD are driving new cases of liver cancer in the US. These are diseases that can be addressed with robust public health measures to reduce downstream ill health #preventativehepatology doi.org/10.1111/apt....
011